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CD28 Signaling via VAV/SLP-76 Adaptors:
Regulation of Cytokine Transcription
Independent of TCR Ligation
By binding to pleckstrin homology (PH) domains, mem-
brane associated D-3 lipids recruit proteins to the inner
face of the plasma membrane (Fruman et al., 1999).
However, although serving as a major site of PI-3-kinase
recruitment, the contribution of the kinase to CD28 sig-
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inositol ring) expression in Jurkat cells (Shan et al., 2000).London, W12 ONN
Constitutive PI 3,4-P2 and PI 3,4,5-P3 expression mayUnited Kingdom
circumvent the need for additional PI-3-kinase. Further,
in vivo reconstitution studies with YMNM mutants have
confirmed the importance of the motif in IL-2 production,Summary
graft versus host responses (Burr et al., 2001; Harada
et al., 2001), and BcL-XL expression (Burr et al., 2001;Since CD28 provides cosignals in T cell responses,
Okkenhaug et al., 2001). The principal target of PI-3-a key question is whether the coreceptor operates
kinase, AKT or protein kinase B (PKB), has also recentlyexclusively via TCR/CD3 or also operates as an inde-
been implicated in regulation of IL-2 production, but notpendent signaling unit. In this study, we show that
Th2 cytokines (Kane et al., 2001). CD28-associated PI-CD28 can cooperate with VAV/SLP-76 adaptors to
3-kinase has also been implicated in 1 integrin adhe-upregulate interleukin 2/4 transcription independently
sion (Zell et al., 1996) and CD28 endocytosis (Cefai etof TCR ligation. CD28 signaling is dependent on VAV/
al., 1998).SLP-76 complex formation and induces membrane lo-
Significantly, despite the importance of the enzyme,calization of these complexes. CD28-VAV/SLP-76 also
other PI-3-kinase-associated receptors cannot substi-functions in nonlymphoid cells to promote nuclear en-
tute for CD28, indicating that another signal is neededtry of NFAT, indicating that these adaptors are the
for costimulation (Schneider et al., 1995b; Stein et al.,only lymphoid components needed for this pathway.
1994). CD28 can promote TCR colocalization with mem-Further downstream, CD28-VAV/SLP-76 synergizes
brane rafts (Viola et al., 1999) and enhance TCR proximalwith Rac1 and causes F-actin remodelling proximal to
signaling (Tuosto and Acuto, 1998). However, althoughreceptor. Autonomous CD28 signaling may account
of importance, these mechanisms do not account forfor the distinct nature of the second signal and in trans
the distinct nature of the CD28 cosignal or for in transamplification of T cell responses.
costimulation (Schwartz, 1990). In this regard, a family
of immune cell-specific adaptor proteins has been iden-Introduction
tified recently that play key roles in T cell activation (for
review, see Peterson et al., 1998; Rudd, 1999; Samelson,Two-signal theory of T cell activation dictates that opti-
1999). Of these, VAV has multiple motifs that include a
mal T cell responses are determined by a TCR signal in
calponin homology domain, guanine nucleotide ex-
conjunction with a second signal provided by a distinct
change factor (GEF) domains, a pleckstrin homology
receptor (Cohn and Langman, 1990; Lafferty and Wool- (PH) domain, a cysteine rich (C-rich) domain, two Src
nough, 1977). CD28 provides a cosignal by enhancing homology 3 (SH3) domains, and a Src homology 2 (SH2)
TCR-regulated cytokine production (Bluestone, 1995; domain (Bustelo, 2000). p56lck-mediated phosphoryla-
Jenkins, 1994) and preventing the induction of anergy tion and D-3 lipid binding regulate GEF activity (Bustelo,
(Schwartz, 1990). Despite its central role, little is known 2000). Vav-deficient mice show defects in activation (Fi-
regarding the molecular basis of cosignaling. The CD28 scher et al., 1998; Tarakhovsky et al., 1995; Zhang et
cytoplasmic YVKM motif binds to the SH2 domains of al., 1995), cytoskeletal reorganization, and TCR capping
phosphatidylinositol 3-kinase (PI-3-kinase), growth fac- (Fischer et al., 1998; Holsinger et al., 1998).
tor receptor-bound protein-2 (GRB-2), Grb-2-related VAV in turn binds to SLP-76, an adaptor with a Sam
GADS/GRID, and protein-tyrosine kinase ITK (for review domain, key tyrosine motifs (YESP, YESP, YEPP), and an
see Rudd, 1996). Additional proline residues mediate sup- SH2 domain (Jackman et al., 1995). SLP-76 binds the VAV
plemental Grb-2/GADS and Lck SH3 domain binding SH2 domain (Onodera et al., 1996; Wu et al., 1996), an
(Holdorf et al., 1999; Kim et al., 1997). PI-3-kinase converts event regulated by ZAP-70/SYK phosphorylation (Raab et
phosphatidylinositol 4-phosphate and phosphatidylinosi- al., 1997; Wardenburg et al., 1996). SLP-76/ mice show
tol 4,5-phosphate to phosphatidylinositol 3,4-phosphate a block at the thymic pre-TCR stage (Clements et al.,
and phosphatidylinositol 3,4,5-phosphate, respectively. 1998; Pivniouk et al., 1998), while TCR signaling is un-
coupled from IL-2 gene activation in SLP-76/ Jurkat
cells (Yablonski et al., 1998). While SLP-76 can function-5 Correspondence: christopher_rudd@dfci.harvard.edu
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ally cooperate with VAV (Wu et al., 1996), complex forma- increased anti-CD3 and anti-CD3/CD28 gene activation,
they failed to support anti-CD28 activation (Figure 1A,tion is not essential for IL-2 transcription (Raab et al.,
1997). VAV also promotes PKC translocation to the cell lower panel). These findings demonstrate a genuine speci-
ficity in the ability of the VAV/SLP-76 adaptors to cooper-surface in T cells (Villalba et al., 2000).
In this study, we show that the VAV/SLP-76 adaptors ate with CD28 in the activation of IL-2 transcription
To establish whether the natural ligand had the samecan endow CD28 with the capacity to independently
regulate IL-2/IL-4 transcription in T cells. FYB and GADS effect as antibody, CD80 on CHO cells was presented
to the transfectants (Figure 1B, upper panel). CD80 en-failed to cooperate with CD28, while mutation of the
SLP-76 YESP sites attenuated cooperativity. Further, gagement of CD28 cooperated with VAV/SLP-76 to acti-
vate IL-2 transcription without the need for TCR ligation.CD28 promoted VAV/SLP-76 complex formation, and
the pathway operated in nonlymphoid cells to promote Indeed, the effect was greater than with antibody, with
30-fold induction of transcription relative to mockNFAT entry into the nucleus, indicating that these adap-
tors are the only lymphoid-specific proteins needed to transfectants. No effect was observed with CHO cells
lacking CD80. Singular expression of VAV or SLP-76connect CD28 with NFAT translocation. The CD28-VAV/
SLP-76 pathway cooperated with Rac1 (but not Rho), occasionally enhanced transcription, but some 10- to
20-fold lower than observed with combined adaptor ex-enhancing actin polymerization at the site of contact
with anti-CD28 on beads. Our findings demonstrate that pression. Immunoblotting of lysates confirmed SLP-76
and VAV expression (Figure 1B, lower panels). CD80CD28 can generate independent signals by cooperating
with VAV/SLP-76/Rac1 in the upregulation of cytokine ligation of CD28 can therefore effectively cooperate with
VAV/SLP-76 in the activation of the IL-2 promoter in thetranscription.
absence of TCR ligation.
As with IL-2 transcription, CD28 ligation of VAV/SLP-76-Results
transfected cells augmented IL-4 transcription, at levels
some 12-fold higher than nonligated cells (Figure 1C).CD28 Cooperates with VAV/SLP-76
VAV or SLP-76 expression alone occasionally enhancedin the Upregulation of IL-2 Transcription
transcription, but at levels some 5- to 10-fold lower thanTo investigate a connection between CD28 and VAV
with the combination, VAV/SLP-76. These data demon-and/or SLP-76, adaptors were transfected, either indi-
strate that the CD28-VAV/SLP-76 pathway can also upreg-vidually or in combination, into Jurkat cells, followed by
ulate IL-4 transcription in the absence of TCR ligation.crosslinking with anti-CD3 and/or anti-CD28 Abs (Figure
1A). IL-2 transcription was assessed by cotransfection
CD28 Cooperativity with VAV/SLP-76 Dependswith an NFAT/AP-1 IL-2 promoter linked to luciferase
on Complex Formation(see Experimental Procedures). Suboptimal concentra-
The VAV SH2 domain binds to two YESP sites at residuestions of antibody were used to approximate low levels
Y113 and Y128 in the N-terminal acidic region on SLP-of receptor engagement. SLP-76 had a moderate po-
76 (Raab et al., 1997). Mutation of either YESP site willtentiating effect on anti-CD3 and anti-CD3/CD28 stimu-
disrupt binding in a cooperative manner (Fang and Ko-lation, as previously reported (Fang et al., 1996), while
retzky, 1999). To assess whether SLP-76 and VAV com-VAV expression had little if any effect (Figure 1A, upper
plex formation was needed for CD28 upregulation ofpanel). Coexpression of SLP-76 and VAV synergistically
IL-2 transcription, single (Y113F, Y128F) YESP and tripleaugmented anti-CD3- and anti-CD3/CD28-induced tran-
(Y113F-Y128F-Y145F) YESP-YESP-YEPP site mutantsscription. Surprisingly, anti-CD28 ligation of cells cotran-
were coexpressed with VAV (Figure 2A, left panel). Thesfected with VAV and SLP-76 also stimulated IL-2 tran-
loss of either YESP motif markedly reduced the abilityscription without the need for TCR/CD3 ligation (Figure
of SLP-76 and VAV to cooperate with CD28 in the upreg-1A, upper panel). Sigificantly, this anti-CD28-mediated
ulation of IL-2 transcription. Further, the reduced capac-stimulation was as great as that observed with anti-CD3.
ity of the single mutants was roughly comparable to thatTransfectants were not nonspecifically hyperactivate,
seen with the triple mutant. The reduced transcriptionalsince ligation of other receptors such as LFA-1 and CD5
enhancement provided by the mutants was equivalentfailed to induce transcription (data not shown). Immu-
to that seen for SLP-76 alone. These findings indicatenoblotting of lysates showed that similar levels of SLP-
that the SH2 domain binding sites on SLP-76 that are76 and VAV were expressed among the transfectants
needed for complex formation are also required for auton-(Figure 1A, middle panel). Anti-HA detected HA-tagged
omous CD28 activation of IL-2 transcription. Blotting dem-SLP-76 (Figure 1A, left middle panel), while anti-VAV
onstrated that the SLP-76 and VAV proteins were ex-detected myc-tagged VAV (Figure 1A, right middle
pressed at similar levels (Figure 2A, right panels).panel). Expression of transfected proteins was only
some 2- to 5-fold higher than endogenous proteins.
We examined whether other SLP-76 binding proteins CD28 Cooperativity with VAV/SLP-76 Is CsA Sensitive
Induction of IL-2 transcription is dependent on cal-could cooperate with SLP-76 to convert CD28 into a
receptor capable of activating transcription (Figure 1A, cineurin (PP2B)-cyclophilin binding and is cyclosporin
A (CsA) sensitive (Rao et al., 1977). CD28 signaling canlower panel). Adaptors GADS and FYB/SLAP interact
with SLP-76 (da Silva et al., 1997; Liu et al., 1999; Musci engage CsA-sensitive and -insensitive pathways (June
et al., 1994). To assess whether CD28-VAV/SLP-76 sig-et al., 1997). However, while the combination of GADS
and SLP-76 potentiated anti-CD3- and anti-CD3/CD28- naling was sensitive to CsA, assays were carried out
in the presence of the drug (Figure 2B). Under theseinduced transcription, they failed to support autono-
mous CD28 activation. Similarly, while SLP-76 and FYB conditions, CsA inhibited anti-CD28-VAV/SLP-76 to the
Independent CD28 Signaling via VAV/SLP-76 Adaptors
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Figure 1. CD28 Cooperates with VAV/SLP-76 in the Upregulation of IL-2 and IL-4 Transcription
(A) (upper panel) Jurkat T cells were subjected to electroporation with either SR vector control (mock), SR SLP-76, or VAV constructs
together with a 3 NFAT/AP-1 (IL-2) promoter luciferase reporter plasmid. Cells were either left unstimulated (dark blue bar) or were stimulated
with anti-CD3 (1 g/ml, red bars), anti-CD28 (1 g/ml, yellow bars) or anti-CD3/CD28 (light blue bars) for 6 hr and assayed for luciferase
activity. (left middle panel) Anti-HA blotting of HA-tagged SLP-76 (lane 1, SR; lane 2, SLP-76; lane 3, VAV; lane 4, SLP-76 and VAV). (right
middle panel) Anti-VAV detected myc-tagged VAV (lanes as in left middle panel). (lower panel) CD28 fails to cooperate with SLP-76 and Gads/
FYB/FYN in the upregulation of IL-2 and IL-4 transcription. SR vector control (mock), SLP-76, Gads, and/or FYB/FYB constructs were
transfected into Jurkat cells together with a 3 NFAT/AP-1 (IL-2) luciferase reporter. Cells were either left unstimulated (dark blue bar) or
were stimulated with anti-CD3 (1 g/ml; red bars) or anti-CD28 (1 g/ml; yellow bars) and anti-CD3/CD28 (light blue bars) for 6 hr and assayed
for luciferase activity. The data represent at least four independent experiments.
(B) Ligation of CD28 by natural ligand CD80 cooperates with VAV/SLP-76 to induce IL-2 transcription independent of TCR ligation. (upper
panel) Following transfection, cells were exposed to etiher CHO cells (dark blue bars) or CHO cells expressing CD80 (red bars) for 6 hr and
assayed for luciferase activity. The data represent at least three independent experiments. (lower panel) Immunblotting detection of transfected
proteins. (left panel) Anti-SLP-76 detected by anti-HA (lane 1, SR; lane 2, SLP-76; lane 3, VAV; lane 4, SLP-76 and VAV). (right panel) Anti-
VAV detected myc-tagged VAV (lanes as in left panel).
(C) CD28 cooperates with VAV/SLP-76 to upregulate IL-4 transcription. Transfection with SLP-76 and/or VAV of Jurkat cells was conducted
with an IL-4 promoter luciferase reporter plasmid. Cells were either left unstimulated (dark blue bar) or were stimulated with anti-CD3 (1 g/
ml, red bars) or anti-CD28 (1 g/ml, yellow bars) for 6 hr and assayed for luciferase activity. The data represent at least three independent
experiments.
same extent as anti-CD3. This observation indicates that ceptor crosslinking (Figure 3A). Membrane and cytosolic
fractions were purified as described (Schneider et al.,CD28 signaling via VAV/SLP-76 participates in the CsA-
sensitive part of CD28 signaling. 1999). Endogenous and transfected VAV were found
preferentially in the cytosol (i.e., 3- to 5-fold higher than
in the membrane), as detected by anti-VAV blotting (Fig-CD28 Ligation Induces Formation of Membrane-
Associated VAV/SLP-76 Complexes ure 3A, middle panel, lanes 1–4 versus 5–8). Further,
while anti-CD28 induced VAV phosphorylation in bothTo obtain information on the mechanism underlying
CD28 engagement of the VAV/SLP-76 adaptors, phos- fractions (Figure 3A, upper panel, lanes 4 and 8), a clear
difference in the relative efficacy of phosphorylation inphorylation and complex formation were determined in
membrane and cytosolic fractions of cells following re- the two fractions was evident when the level of protein
Immunity
924
Figure 2. SLP-76 YESP Mutations and Cyclosporin A Attenuate CD28 Induction of IL-2 Transcription
(A) (left panel) VAV/SLP-76 binding mutants are defective in supporting CD28 induction of IL-2 transcription. Jurkat cells were transfected
with SR vector control (mock) or VAV together with either SLP-76 WT, SLP-76 Y113/128/145F, SLP-76 Y113F, or SLP-76 Y128F constructs.
Cells were either left unstimulated (dark blue bars) or were stimulated with anti-CD28 (1 g/ml; yellow bars) for 6 hr and assayed for luciferase
activity. (right panel) Level of SLP-76 and VAV expression. (upper panel) Anti-HA detected HA-tagged SLP-76 (lane 1, mock; lane 2, SLP-76
WT; lane 3, VAV; lane 4, SLP-76 WT/VAV; lane 5, SLP-76 Y113/128/145F (F1-3)/VAV; lane 6, SLP-76 Y113/VAV; lane 7, SLP-76 Y128/VAV).
(lower panel) Anti-VAV detected myc-tagged VAV (lanes as in upper panel).
(B) CD28-VAV/SLP-76 pathway is cyclosporin A (CsA) sensitive. Jurkat cells were either left unstimulated (dark blue bar) or were stimulated
with anti-CD3 (1 g/ml; red bars) or anti-CD28 (1 g/ml; yellow bars) and anti-CD3/CD28 (light blue bars) for 6 hr in the absence or presence
of CsA (10 M).
expression was contrasted with the level of phosphory- tation of VAV, were found exclusively in the membrane
fraction (Figure 3A, middle panel, lanes 15 and 16). Fur-lation. From this, CD28 ligation induced a 5-fold prefer-
ential phosphorylation of VAV in the membrane fraction. ther, the level of VAV-SLP-76 binding increased slightly
with anti-CD28 crosslinking (Figure 3A, middle panel,Endogenous and transfected SLP-76 was also more
prevalent in the cytosol (i.e., more than 5- to 10-fold lanes 15 and 16).
To examine the state of endogenous protein, thehigher levels), as detected by anti-SLP-76 blotting of
lysates (Figure 3A, lower panel, lanes 1–4 versus 5–8) membrane fraction was doubly extracted in detergent,
a step that increased yields considerably (Figure 3B).and anti-SLP-76 precipitates (Figure 3A, lower panel,
lanes 9–12 versus 13–16). Anti-CD28 increased phos- Under this regime, VAV/SLP-76 complexes were also
found exclusively in the membrane fraction (Figure 3B,phorylation of this adaptor in both fractions (Figure 3A,
upper panel, lanes 9–16). However, significantly, com- lower panel, lanes 5 and 6 versus 7 and 8), despite the
presence of SLP-76 in both fractions (Figure 3B, upperplexes of VAV/SLP-76, as detected by SLP-76 coprecipi-
Independent CD28 Signaling via VAV/SLP-76 Adaptors
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Figure 3. CD28 Ligation Promotes Formation
of Membrane-Associated VAV/SLP-76 Com-
plexes
(A) CD28 ligation causes enhanced VAV/SLP-
76 tyrosine phosphorylation and complex for-
mation in the membrane fraction. (upper
panel) Anti-phosphotyrosine blotting of Jur-
kat cell lysates and anti-SLP-76 precipitates
from cytosolic and membrane fractions.
Membrane and cytosolic fractions were iso-
lated as described in Experimental Proce-
dures (lysates, lanes 1–8; anti-SLP-76 precip-
itates, lanes 9–16; cytosolic fraction, lanes
1–4 and 9–12; membrane fraction, lanes 5–8
and 13–16). (middle panel) Anti-VAV blotting
of lysates and anti-SLP-76 precipitates from
cytosolic and membrane fractions. (lower
panel) Anti-SLP-76 blotting of lysates and
anti-SLP-76 precipitates from cytosolic and
membrane fractions.
(B) CD28 ligation induces the formation of en-
dogenous VAV/SLP-76 complexes in T cells.
Nontransfected Jurkat cells were either left
untreated or were subjected to anti-CD28
crosslinking for 10 min prior to the purification
of membrane and cytosolic fractions. The
modified isolation of membranes (i.e., double
extraction) was conducted as described in
Experimental Procedures (lysates, lanes 1–4;
anti-SLP-76 precipitates, lanes 5–8). Lysates
and precipitates were subjected to blotting
with anti-SLP-76 (upper panel, lanes 1–8) or
anti-VAV (lower panel, lanes 1–8).
panel, lanes 5–8). Further, anti-CD28 caused a 2- to As seen in Figure 4A, CHO-CD80 induced IL-2 produc-
tion selectively in doubly VAV/SLP-76 transfected cells4-fold increase in the amount of endogenous VAV that
coprecipitated with anti-SLP-76 from membranes (Fig- (Figure 4A, left panel). Specificity was shown by the
absence of an effect by CHO cells lacking CD80 and byure 3B, lower panel, lane 7 versus 8). No complexes
were evident in the cytosolic fraction. Significantly, our the inability of singly transfected cells to respond. Given
that activated T cells also express CTLA-4, an alternatefindings show that anti-CD28 can selectively induce the
formation of VAV/SLP-76 complexes in the membranes ligand for CD80, anti-CD28 antibody was also used and
found to induce IL-2 production in VAV/SLP-76 transfec-of T cells.
tants (Figure 4A, right panel). Receptor ligation was not
effective in singly transfected cells (data not shown).
CD28-VAV/SLP-76 Pathway Functions SLP-76 and VAV were expressed at similar levels in
transfectants (i.e., higher Mr due to HA and Y/GFP tags)in Normal Peripheral T Cells
Jurkat cells are abnormal in lacking the lipid phospha- (Figure 4A, lower left panel).
CD28 ligation could also induce complex formationtase PTEN (Shan et al., 2000). To assess whether the
CD28-VAV/SLP-76 pathway could operate in normal between endogenous VAV and SLP-76 in peripheral T
cells. Anti-CD28 crosslinking induced SLP-76 phos-T cells, purified human T cells were stimulated for 48 hr
followed by transfection or infection with VAV and/or phorylation in both the cytosolic and membrane frac-
tions (Figure 4B, upper panel, lanes 2 and 4), while anti-SLP-76 (see Experimental Procedures). CD28 was then
crosslinked with CHO cells expressing CD80 or with VAV blotting of SLP-76 precipitates showed the re-
stricted presence of VAV/SLP-76 complexes in theanti-CD28, followed by a measurement of IL-2 secretion.
Immunity
926
Figure 4. CD28 Cooperates with VAV/SLP-76 in Normal Human Peripheral T Cells
(A) CD28 cooperates with VAV/SLP-76 in peripheral T cells to induce IL-2 transcription. (upper panel) Purified human T cells were activated
for 48 hr followed by transfection with YFP-SLP-76 and/or GFP-VAV as described in Experimental Procedures. Cells were cultured with CHO-
CD80 (left panel) or with anti-CD28 (right panel), followed by a measurement of IL-2 production. (lower panels) Immunoblotting for detection
of transfected proteins. Anti-Ha blotting of lysates detected YFP-HA-SLP-76 expression (upper panel), while anti-VAV blotting detected an
increase in GFP-VAV expression with transfection (lower panel). (Mrs are somewhat higher due to the presence of an additional GSP/YFP
tag).
(B) CD28 ligation induces the formation of endogenous VAV/SLP-76 complexes in peripheral T cells. Nontransfected peripheral cells were
either left untreated or were subjected to anti-CD28 crosslinking for 10 min prior to the purification of cytosolic (lanes 1 and 2) and membrane
(lanes 3 and 4) fractions. Anti-SLP-76 precipitates from the two fractions were then subjected to blotting with anti-ptyr (4G10) (upper panel,
lanes 1–4) or anti-VAV (lower panel, lanes 1–4).
membrane fraction (Figure 4B, upper panel, lanes 1 and assess this question further, stable transfectants of non-
2 versus 3 and 4). Moreover, anti-CD28 induced an in- lymphoid COS cells were derived that expressed CD28.
crease in the presence of VAV/SLP-76 complexes selec- These cells were transiently transfected with VAV and/
tively in the membranes (Figure 4B, lower panel, lanes or SLP-76 and GFP-tagged NFAT and assessed for an
3 and 4). Our findings therefore show that CD28 can ability to promote NFAT entry into the nucleus (Figure
induce VAV/SLP-76 complex formation and cooperate 5). Untreated (Figures 5A–5D) or anti-CD28-crosslinked
with the adaptors to upregulate IL-2 production in nor- cells (Figures 5A–5D) were visualized for VAV and/or
mal peripheral T cells. IL-2 transcription and bona fide SLP-76 by the use of a secondary antibody coupled to
IL-2 release can both be upregulated by the pathway. Texas-red (TxR). Figure 5A shows the presence of NFAT-
GFP in the cytoplasm of COS cells with no evidence of
nuclear staining (three nuclei can be seen in the top halfCD28-VAV/SLP-76 Drives NFAT into the Nucleus
of the cell). Figure 5A shows the same GFP-taggedof COS Cells
NFAT-transfected COS cells after exposure to anti-CD28-VAV/SLP-76 regulation of cytokine transcription
CD28 for 15 min. Staining with anti-RaM-TxR showedwithout ligation of TCR suggests that CD28 engages the
the presence of cell surface CD28, while no nuclearadaptors in an independent manner (i.e., operates as
staining with NFAT-GFP was evident. Similarly, in cellsan independent signaling unit). CD28-VAV/SLP-76 could
transfected with SLP-76, neither untreated nor receptor-induce cytokine transcription in putative TCR/CD3-neg-
crosslinked cells showed evidence of nuclear NFAT-ative Jurkat T cells; however, we detected low levels of
CD3 expression on these cells (data not shown). To GFP (Figures 5B and 5B, respectively). The diffuse yel-
Independent CD28 Signaling via VAV/SLP-76 Adaptors
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Figure 5. CD28-VAV/SLP-76 Drives NFAT
into the Nucleus of COS Cells
CD28-expressing COS cells, transfected with
SLP-76-HA and/or VAV-Myc and NFAT-GFP,
were either left untreated (A–D) or were sub-
jected to crosslinking with anti-CD28 for 15
min (A–D). Immunofluorescence micros-
copy was conducted as described in Experi-
mental Procedures. (A), untreated cells; (A),
anti-CD28 and stained with RaM-TxR; (B),
NFAT-GFP and SLP-76-Ha; (B), crosslinked
cells expressing NFAT-GFP and SLP-76-Ha
(in both [B] and [B], cells were stained with
anti-HA and IG2b-TxR-labeled secondary an-
tibody); (C), NFAT-GFP and VAV-myc; (C),
crosslinked cells expressing NFAT-GFP and
VAV-myc (cells were stained with anti-myc/
RaM-TxR); (D), NFAT-GFP, SLP-76-Ha, and
VAV-myc; (D), crosslinked CD28-COS ex-
pressing NFAT-GFP, SLP-76-Ha, and VAV-
myc (cells were stained with anti-Ha [12CA5]
and IG2b-TxR-labeled secondary antibody).
low emission was due to the colocalization of TxR stain- of NFAT required anti-CD28 ligation, since it was not
evident in untreated cells (Figure 5D versus 5D). Theseing and GFP-tagged NFAT in the cytoplasm. With VAV
transfectants, while untreated cells showed no nuclear observations demonstrate that CD28 ligation of COS
cells expressing a combination of VAV and SLP-76 isNF-AT (Figure 5C), anti-CD28-crosslinked cells showed
primarily cytoplasmic NFAT with occasional cells with sufficient to induce NFAT migration into the nucleus of
COS cells. This finding further underscores the abilitylimited dot-like nuclear staining (Figure 5C). In the case
of the double VAV/SLP-76 transfectants, untreated of CD28 to engage VAV/SLP-76 as an independent sig-
naling unit and shows that VAV and SLP-76 are theCD28-positive cells showed no evidence of nuclear
staining (Figure 5D). However, unlike the previous situa- only lymphoid-specific components needed for CD28
regulation of NFAT entry into the nucleus.tions, anti-CD28 ligation resulted in the appearance of
a well-defined population of cells with intense NFAT
nuclear staining (Figure 5D). Some 5%–8% of COS cells Rac 1 Synergizes with CD28-Mediated
VAV/SLP-76 Signalingwere found to be transfected with VAV, SLP-76, and
GFP-tagged NFAT, as assessed by independent stain- VAV possesses guanine nucleotide exchange activity
(GEF) for the GTP binding protein Rac1 (Bustelo, 2000),ing with the appropriate antibody (data not shown). Of
these, at least 50% of these cells showed a remarkably while CD28 ligation can induce cytoskeletal reorganiza-
tion (Kaga et al., 1998). VAV/SLP-76 complex formationintense localization of NFAT in the nucleus with negligi-
ble GFP-NFAT in the cytoplasm. The nuclear localization might, therefore, serve as an intermediate in a pathway
Immunity
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Figure 6. Rac1 Synergizes with CD28-Mediated VAV/SLP-76 Signaling
(A) Rac1 (but neither Rac N17 nor Rho) synergizes with VAV/SLP-76 in CD28-mediated signaling. (left panel) Jurkat T cells were transfected
with either vector, SLP-76, VAV, Rac1 WT, Rac1N17, and/or Rho WT together with the 3 NFAT/AP-1 (IL-2) luciferase promoter plasmid as
described in Experimental Procedures. Cells were either left unstimulated (blue bars) or were stimulated with anti-CD3 (1 g/ml; red bars) or
anti-CD28 (1 g/ml; yellow bars) for 6 hr and assayed for luciferase activity. The data represent at least three independent experiments. (right
panel) Immunoblotting for SLP-76 and VAV expression. (upper panel) Anti-HA detection of HA-tagged SLP-76. (middle panel) Anti-VAV detection
of myc-tagged VAV. (lower panel) Anti-GST detected GST-tagged Rac and Rho.
(B) VAV/SLP-76 binding mutants are defective in support of CD28-VAV/SLP-76/Rac 1 cooperativity. Jurkat T cells were cotransfected with
SR vector control (mock), SLP-76 WT, VAV, Rac1 WT, Rac1N17, SLP-76 Y113/128/145F, and/or SLP-76 Y113F together with a 3 NFAT/
AP-1 (IL-2) promoter luciferase reporter. Cells were either unstimulated (dark blue bars) or were stimulated with anti-CD28 (1 g/ml; red bars)
for 6 hr and assayed for luciferase activity. The data represent at least three independent experiments.
linking CD28 to Rac1. To address this, VAV, SLP-76, also disrupt CD28-VAV/SLP-76/Rac1 cooperativity (Fig-
ure 6B). Indeed, each of the SLP-76 YESP mutants wasand Rac1 were coexpressed with an IL-2 promoter
construct, followed by crosslinking with anti-CD28 or impaired in its ability to cooperate with VAV and Rac1
in CD28 signaling. Further, the level of impairment wasanti-CD3 (Figure 6A). Significantly, Rac1 coexpression
potentiated CD28-VAV/SLP-76 activation of IL-2 tran- comparable for both CD28-VAV/SLP-76 and CD28-VAV/
SLP-76/Rac1 signaling. These data are consistent withscription by some 6- to 10-fold. This cooperativity was
observed between Rac1 and the combination of VAV the notion that CD28 engagement of VAV/SLP-76 com-
plexes can cooperate with Rac1 along the same path-and SLP-76 to a much greater degree than with VAV or
SLP-76 alone. Anti-CD3 stimulation was also potenti- way in the regulation of IL-2 transcription.
ated by the combined VAV/SLP-76/Rac1 expression.
Specificity was further shown by the inability of related CD28 Stimulation in the Presence of the VAV/SLP-76
Complex Enhances F-Actin PolymerizationRho to synergize with CD28-VAV/SLP-76. Further,
Rac1N17 also failed to cooperate and often inhibited The connection with Rac1 suggested that CD28-VAV/
SLP-76 might alter the organization of the actin cytoskel-the potentiation. Various proteins were expressed at
similar levels as observed by blotting (Figure 6A, right eton. Rac1 regulates actin polymerization and may influ-
ence transcription by altering the cytoskeleton or viapanel). Lastly, for VAV/SLP-76/Rac1 to operate along
the same pathway (i.e., a linear pathway), the same mu- an alternate signal. Yellow fluorescence protein (YFP)-
tagged SLP-76 and a green fluorescence protein (GFP)-tations that disrupt CD28-VAV/SLP-76 signaling should
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Figure 7. CD28-VAV/SLP-76 Enhances F-Actin Polymerization in T Cells
(A) CD28 cooperates with YFP-SLP-76/GFP-VAV in Jurkat T cells to upregulate IL-2 transcription. (upper panel) Jurkat T cells were transfected
with SR vector control (mock), YFP-HA-SLP-76, and/or GFP-HA-VAV together with a 3 NFAT/AP-1 (IL-2) promoter luciferase reporter
plasmid. Cells were either unstimulated (dark blue bars) or were stimulated with anti-CD3 (1 g/ml; red bars) or anti-CD28 (1 g/ml; yellow
bars) for 6 hr and assayed for luciferase activity. (lower panel) Immunoblotting detection of SLP-76 and VAV expression with anti-HA antibody.
(B) CD28-YFP-SLP-76/GFP-VAV induces F-actin polymerization at the site of CD28 ligation. Singly and doubly transfected YFP and GFP
expressing cells were sorted by two-color FACS as described in Experimental Procedures. Immunofluorescence visualization of F-actin by
TRITC-phalloidin staining of singly and doubly YFP-HA-SLP-76- and GFP-HA-VAV-transfected cells exposed to anti-CD28 coated beads.
(upper panel) Singly YFP-SLP-76-transfected cells (upper row). Singly GFP-VAV-transfected cells (middle row). Doubly YFP-SLP-76- and GFP-
VAV-transfected cells (lower row). (lower panel) Histogram showing the number of cells that showed TRITC-phalloidin stained subcaps in
single- and double-expressing YFP-HA-SLP-76/GFP-HA-VAV Jurkat cells.
tagged VAV were used together with TRITC-phalloidin changes in the cytoskeletal concentration at the point of
contact with the anti-CD28 beads. The point of contactto detect F-actin. GFP-VAV and YFP-SLP-76 retained
an ability to cooperate with CD28 to induce IL-2 tran- showed a subcap of yellow fluorescence due to the
coincident localization of GFP-VAV/YFP-SLP-76 andscription in Jurkat cells (Figure 7A). Blotting showed the
expression of the YFP and GFP versions of the proteins, TRITC-phalloidin staining. Similar increases in the num-
ber of cells with TRITC-phalloidin-labeled subcaps wereeach with an additional 25 kDa Mr (Figure 7A, lower
panel). Next, doubly transfected cells were sorted by observed in unseparated cells that had been cotrans-
fected with VAV and SLP-76 (data not shown). GFP-VAVtwo-color FACS and exposed to Dynabeads coated with
anti-CD28 for a 3 hr incubation (Figure 7B). From this it and YFP-SLP-76 appeared green by microscopy due to
technical limitations with the available filters. Our obser-was evident that cells coexpressing GFP-VAV and YFP-
SLP-76 showed significantly greater F-actin polymeriza- vations therefore show that CD28-VAV/SLP-76 signaling
is associated with the reorganization of the actin cy-tion at the point of contact with the anti-CD28 beads
(Figure 7B, upper panel, lower row) than singly trans- toskeleton at the point of contact with CD28.
fected cells (Figure 7B, upper panel, upper and middle
row). As shown by histogram representation (Figure 7B, Discussion
lower panel), 5%–10% of singly transfected cells
showed some increase in TRITC-phalloidin staining at Despite the importance of CD28 in T cell immunity, the
signaling events responsible for its function have yet tothe site of contact with beads. By contrast, over 70%
of the doubly transfected cells showed detectable be fully defined. Although CD28 can upregulate early
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TCR signaling events (Tuosto and Acuto, 1998; Viola et 1997). With this, CD28 could indirectly facilitate SLP-76
interactions with other components, such as GADS oral., 1999), these events do not readily account for in
trans costimulation and the unique nature of the CD28 FYB/SLAP, or alter GEF activity for Rac1.
Identification of an independent CD28-VAV/SLP-76cosignal (Schwartz, 1990). One central issue has been
whether CD28 operates solely through the TCR/CD3 pathway may account for hitherto unexplained aspects
of CD28 function, such as in trans cosignaling. In thiscomplex, or whether it can also act as an independent
signaling unit. In this study, we demonstrate that CD28 context, direct engagement of VAV/SLP-76 would be
less dependent on proximal cross-talk between CD28can act as a bona fide signaling unit with the capacity to
independently cooperate with VAV/SLP-76 in regulating and TCR and may account for ability of certain anti-
CD28 antibodies to activate T cells (Siefken et al., 1998;cytokine transcription. Coexpression of VAV and SLP-76
conferred to CD28 an ability to regulate NFAT function in Tacke et al., 1997). Unusual forms of CD28 engagement
by antibody ligand may be found to interface with VAV/the absence of TCR ligation. By contrast, the coreceptor
failed to cooperate with SLP-76 and its other binding SLP-76 in ways that lead to a complete signal. Under
normal conditions of ligation, the pathway would not bepartners FYB/SLAP and GADS. Further, signaling was
dependent on adaptor interaction, since SLP-76 YESP fully utilized, due to lower levels of protein expression,
and would instead generate a partial or incomplete sig-mutants that are defective in binding VAV showed mark-
edly reduced signaling. CD28 ligation also promoted nal that complements TCR signaling.
Given the requirement of VAV and SLP-76 in TCRVAV/SLP-76 complex formation of both transfected and
endogenous proteins. Importantly, CD28-VAV/SLP-76 signaling, knockout models have been limited in provid-
ing information on their role in costimulation. Indirectsignaling operated in peripheral T cells and in non-
lymphoid COS cells to promote NFAT nuclear entry. evidence implicating VAV has been observed in Cbl-b-
deficient mice, which show concordant changes in VAVThis surprising latter finding underscored the identity of
CD28 as a signaling unit that can operate independently phosphorylation and CD28 dependency (Bachmaier et
al., 2000; Chiang et al., 2000). Further, Michel and col-of the TCR complex and demonstrated that VAV and
SLP-76 are the only lymphoid-specific components leagues have reported that VAV overexpression permits
anti-CD28 induction of IL-2 transcription that is depen-needed for the pathway. Lastly, CD28-VAV/SLP-76 syn-
ergized with Rac1 and altered the cytoskeletal organiza- dent on TCR/CD3 expression (Michel et al., 2000). Our
studies failed to find an effect of VAV alone (perhapstion at the point of contact with anti-CD28 on beads
(Figure 7). Our findings therefore show that VAV/SLP- due to lower expression levels) and found that VAV-
SLP-76 interaction operated independently of TCR/76 can cooperate in a specific manner to allow CD28
to independently regulate aspects of T cell function. CD3 expression. These combined studies suggest that
VAV has the capacity to modulate more than one signal-Previous studies have shown that CD28 can enhance
T cell activation and prevent the induction of anergy ing event. This is in keeping with the general notion of
adaptors as proteins with multiple discrete modules that(Bluestone, 1995; Schwartz, 1990; Jenkins, 1994) (termed
signals 2c for costimulation and 2t for tolerance) (Bach- can mediate discrete events (Peterson et al., 1998;
Rudd, 1999; Samelson, 1999).mann et al., 1997). Previously defined CD28-associated
PI-3-kinase is likely to have a pleiotropic effect where The independence of CD28-VAV/SLP-76 signaling
was underscored by its ability to function in non-the increased expression of D-3 lipids can promote bind-
ing of multiple PH domains carrying proteins to the lymphoid COS cells to promote NFAT nuclear entry,
indicating that these adaptors are the only lymphoid-plasma membrane (Rudd, 1996). However, since other
PI-3-kinase-associated receptors fail to substitute for specific components needed for the pathway. Src ki-
nases and Rac1 are already expressed in nonlymphoidCD28, a more specialized pathway must also exist
(Schneider et al., 1995b; Stein et al., 1994). Signal 2c cells. In keeping with this, CD28-VAV/SLP-76 also coop-
erated with Rac1, but not the related family membermay therefore comprise more than one pathway. Early
studies suggested distinct CD28 regulation of cGMP Rho or an N17 mutant of Rac1. Further, SLP-76 YESP
mutants were also defective in cooperating with Rac1,and phospholipase C (Ledbetter et al., 1990). CD28-
VAV-SLP-76 signaling offers the complementary fea- demonstrating the importance of VAV/SLP-76 complex
formation in bridging CD28 with Rac1 (i.e., a linear path-tures of an independent pathway and one that intersects
with components used by the TCR/CD3 complex. Previ- way). Consistent with this, coexpressing T cells showed
enhanced actin polymerization at the site of contact withous studies have documented the importance of VAV
and SLP-76 in TCR-induced IL-2 expression (Fischer et anti-CD28 on beads. Kaga et al. (1998) have previously
reported that CHO-CD80 cells can induce cytoskeletalal., 1998; Holsinger et al., 1998; Yablonski et al., 1998). By
intersecting with components of TCR signaling, CD28- rearrangements in T cells. Although our experiments did
not show actin reorganization with anti-CD28 on beadsVAV/SLP-76 could amplify suboptimal TCR signals and
reduce the number of TCR receptors needed for a pro- alone (i.e., instead requiring some VAV/SLP-76 overex-
pression), both sets of findings support the notion ofductive response. VAV/SLP-76 may also be providing
key components of TCR signaling that cooperate with independent CD28 signaling. Our findings now suggest
that VAV/SLP-76 complex formation is a key event thatCD28. However, the fact that CD28 can itself promote
complex formation between these proteins indicates bridges CD28 with the Rac1 GTPase.
Importantly, our findings and those showing thatthat it can also independently engage these proteins.
This could serve as the basis for a distinct second signal CD28 can promote TCR signaling are not mutually exclu-
sive. CD28 promotion of raft expression may representand is supported by the dependency of CD28 on the
VAV/SLP-76 interaction, a dependency less evident with the first event that cooperates with CD28-VAV/SLP-76 sig-
naling. Subsequent cooperativity between VAV/SLP-76TCR signaling (Fang and Koretzky, 1999; Raab et al.,
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coated Dynabeads (M-450 tosyl activated from Dynal) for 3 hr onand Rac1 could then facilitate actin subcap formation
ice. After activation for 10 min at 37	C, cells were fixed and perme-under the membrane raft. The upstream link to CD28
abilized and stained for F-actin with Phalloidin-TRITC. Slides werecould involve PI-3-kinase, GRB-2/GADS, LCK, and/or
mounted in a polyvinyl alcohol medium and viewed on a Nikon FXA
ITK. GRB-2 binds VAV, while GADS has been reported microscope equipped for epifluorescence.
to interact with SLP-76 (Liu et al., 1999). One scenario
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